These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 37893577)

  • 1. Exploring Verbal Fluency Strategies among Individuals with Normal Cognition, Amnestic and Non-Amnestic Mild Cognitive Impairment, and Alzheimer's Disease.
    Bairami S; Folia V; Liampas I; Ntanasi E; Patrikelis P; Siokas V; Yannakoulia M; Sakka P; Hadjigeorgiou G; Scarmeas N; Dardiotis E; Kosmidis MH
    Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893577
    [No Abstract]   [Full Text] [Related]  

  • 2. Language Differences Among Individuals with Normal Cognition, Amnestic and Non-Amnestic MCI, and Alzheimer's Disease.
    Liampas I; Folia V; Morfakidou R; Siokas V; Yannakoulia M; Sakka P; Scarmeas N; Hadjigeorgiou G; Dardiotis E; Kosmidis MH
    Arch Clin Neuropsychol; 2023 May; 38(4):525-536. PubMed ID: 36244060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of verbal fluency ability in amnestic and non-amnestic mild cognitive impairment.
    Weakley A; Schmitter-Edgecombe M; Anderson J
    Arch Clin Neuropsychol; 2013 Nov; 28(7):721-31. PubMed ID: 23917346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olfactory identification in amnestic and non-amnestic mild cognitive impairment and its neuropsychological correlates.
    Vyhnalek M; Magerova H; Andel R; Nikolai T; Kadlecova A; Laczo J; Hort J
    J Neurol Sci; 2015 Feb; 349(1-2):179-84. PubMed ID: 25614440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Examination of Semantic Impairment in Amnestic MCI and AD: What Can We Learn From Verbal Fluency?
    Chasles MJ; Tremblay A; Escudier F; Lajeunesse A; Benoit S; Langlois R; Joubert S; Rouleau I
    Arch Clin Neuropsychol; 2019 Jan; 35(1):22-30. PubMed ID: 30994886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verbal fluency patterns associated with the amnestic conversion from mild cognitive impairment to dementia.
    Cintoli S; Favilli L; Morganti R; Siciliano G; Ceravolo R; Tognoni G
    Sci Rep; 2024 Jan; 14(1):2029. PubMed ID: 38263387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qualitative Verbal Fluency Components as Prognostic Factors for Developing Alzheimer's Dementia and Mild Cognitive Impairment: Results from the Population-Based HELIAD Cohort.
    Liampas I; Folia V; Zoupa E; Siokas V; Yannakoulia M; Sakka P; Hadjigeorgiou G; Scarmeas N; Dardiotis E; Kosmidis MH
    Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557016
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk of progression to Alzheimer's disease for different neuropsychological Mild Cognitive Impairment subtypes: A hierarchical meta-analysis of longitudinal studies.
    Oltra-Cucarella J; Ferrer-Cascales R; Alegret M; Gasparini R; Díaz-Ortiz LM; Ríos R; Martínez-Nogueras ÁL; Onandia I; Pérez-Vicente JA; Cabello-Rodríguez L; Sánchez-SanSegundo M
    Psychol Aging; 2018 Nov; 33(7):1007-1021. PubMed ID: 30284855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical relevance of amnestic versus non-amnestic mild cognitive impairment subtyping in Parkinson's disease.
    Chung SJ; Park YH; Yun HJ; Kwon H; Yoo HS; Sohn YH; Lee JM; Lee PH
    Eur J Neurol; 2019 May; 26(5):766-773. PubMed ID: 30565368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiating amnestic from non-amnestic mild cognitive impairment subtypes using graph theoretical measures of electroencephalography.
    Kim JG; Kim H; Hwang J; Kang SH; Lee CN; Woo J; Kim C; Han K; Kim JB; Park KW
    Sci Rep; 2022 Apr; 12(1):6219. PubMed ID: 35418202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Differentiation of Amnestic Type MCI from the Non-Amnestic Types by Structural MRI.
    Csukly G; Sirály E; Fodor Z; Horváth A; Salacz P; Hidasi Z; Csibri É; Rudas G; Szabó Á
    Front Aging Neurosci; 2016; 8():52. PubMed ID: 27065855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain metabolism and cerebrospinal fluid biomarkers profile of non-amnestic mild cognitive impairment in comparison to amnestic mild cognitive impairment and normal older subjects.
    Coutinho AM; Porto FH; Duran FL; Prando S; Ono CR; Feitosa EA; Spíndola L; de Oliveira MO; do Vale PH; Gomes HR; Nitrini R; Brucki SM; Buchpiguel CA
    Alzheimers Res Ther; 2015 Sep; 7(1):58. PubMed ID: 26373380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of functional connectivity of the executive control network or default mode network with cognitive impairment in older adults with remitted major depressive disorder or mild cognitive impairment.
    Rashidi-Ranjbar N; Rajji TK; Hawco C; Kumar S; Herrmann N; Mah L; Flint AJ; Fischer CE; Butters MA; Pollock BG; Dickie EW; Bowie CR; Soffer M; Mulsant BH; Voineskos AN
    Neuropsychopharmacology; 2023 Feb; 48(3):468-477. PubMed ID: 35410366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quanti-qualitative components of the semantic verbal fluency test in cognitively healthy controls, mild cognitive impairment, and dementia subtypes.
    Wajman JR; Cecchini MA; Bertolucci PHF; Mansur LL
    Appl Neuropsychol Adult; 2019; 26(6):533-542. PubMed ID: 30375889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbid cerebral amyloid angiopathy in dementia and prodromal stages-Prevalence and effects on cognition.
    Haussmann R; Homeyer P; Sauer C; Grey A; Krukowski P; Brandt MD; Donix M; Linn J
    Int J Geriatr Psychiatry; 2023 Oct; 38(10):e6015. PubMed ID: 37847104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired generation of new subcategories and switching in a semantic verbal fluency test in older adults with mild cognitive impairment.
    Bertola L; Cunha Lima ML; Romano-Silva MA; de Moraes EN; Diniz BS; Malloy-Diniz LF
    Front Aging Neurosci; 2014; 6():141. PubMed ID: 25071550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study.
    Kida J; Nemoto K; Ikejima C; Bun S; Kakuma T; Mizukami K; Asada T
    J Alzheimers Dis; 2016; 51(2):405-15. PubMed ID: 26890740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graph analysis of verbal fluency test discriminate between patients with Alzheimer's disease, mild cognitive impairment and normal elderly controls.
    Bertola L; Mota NB; Copelli M; Rivero T; Diniz BS; Romano-Silva MA; Ribeiro S; Malloy-Diniz LF
    Front Aging Neurosci; 2014; 6():185. PubMed ID: 25120480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.
    Visser PJ; Verhey F; Knol DL; Scheltens P; Wahlund LO; Freund-Levi Y; Tsolaki M; Minthon L; Wallin AK; Hampel H; Bürger K; Pirttila T; Soininen H; Rikkert MO; Verbeek MM; Spiru L; Blennow K
    Lancet Neurol; 2009 Jul; 8(7):619-27. PubMed ID: 19523877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairment.
    Dugger BN; Davis K; Malek-Ahmadi M; Hentz JG; Sandhu S; Beach TG; Adler CH; Caselli RJ; Johnson TA; Serrano GE; Shill HA; Belden C; Driver-Dunckley E; Caviness JN; Sue LI; Jacobson S; Powell J; Sabbagh MN
    BMC Neurol; 2015 Aug; 15():146. PubMed ID: 26289075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.